Label-free impedance flow cytometry for nanotoxicity screening

The development of reliable and cost-efficient methods to assess the toxicity of nanomaterials (NMs) is critical for the proper identification of their impact on human health and for ensuring a safe progress of nanotechnology. In this study, we investigated the reliability and applicability of label-free impedance flow cytometry (IFC) for in vitro nanotoxicity screening, which avoids time-consuming labelling steps and minimizes possible NM-induced interferences. U937 human lymphoma cells were exposed for 24 h to eight different nanomaterials at five concentrations (2, 10, 20, 50, and 100 μg/mL). The NMs’ effect on viability was measured using IFC and the results were compared to those obtained by trypan blue (TB) dye exclusion and conventional flow cytometry (FC). To discriminate viable from necrotic cells, the IFC measurement settings regarding signal trigger level and frequency, as well as the buffer composition, were optimised. A clear discrimination between viable and necrotic cells was obtained at 6 MHz in a sucrose-based measurement buffer. Nanomaterial-induced interferences were not detected for IFC. The IFC and TB assay results were in accordance for all NMs. The IFC was found to be robust, reliable and less prone to interferences due to the advantage of being label-free.

[1]  H. Kalantari,et al.  Nanotoxicology , 2013, Jundishapur journal of natural pharmaceutical products.

[2]  Pratim Biswas,et al.  Assessing the risks of manufactured nanomaterials. , 2006, Environmental science & technology.

[3]  B. Nemery,et al.  Intracellular oxidative stress caused by nanoparticles: What do we measure with the dichlorofluorescein assay? , 2013 .

[4]  Philip Demokritou,et al.  Estimating the effective density of engineered nanomaterials for in vitro dosimetry , 2014, Nature Communications.

[5]  Alfredo Franco-Obregón,et al.  Impedance flow cytometry gauges proliferative capacity by detecting TRPC1 expression , 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[6]  R Damoiseaux,et al.  No time to lose--high throughput screening to assess nanomaterial safety. , 2011, Nanoscale.

[7]  Cynthia Ong,et al.  Nanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell Death , 2015, Nanomaterials.

[8]  Blanca Suarez-Merino,et al.  High throughput toxicity screening and intracellular detection of nanomaterials , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[9]  Heidi Goenaga-Infante,et al.  Dynamic monitoring of metal oxide nanoparticle toxicity by label free impedance sensing. , 2012, Chemical research in toxicology.

[10]  Joseph P. Kerry,et al.  Nanotechnologies in the food industry – Recent developments, risks and regulation , 2012 .

[11]  P. Goering,et al.  Flow cytometry evaluation of in vitro cellular necrosis and apoptosis induced by silver nanoparticles. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  Fatimah Ibrahim,et al.  The Theory and Fundamentals of Bioimpedance Analysis in Clinical Status Monitoring and Diagnosis of Diseases , 2014, Sensors.

[13]  M. Gehlen,et al.  Fluorescence Modulation of Acridine and Coumarin Dyes by Silver Nanoparticles , 2007, Journal of Fluorescence.

[14]  Linsinger Thomas,et al.  NM-300 Silver Characterisation, Stability, Homogeneity , 2011 .

[15]  Philip Demokritou,et al.  An integrated approach for the in vitro dosimetry of engineered nanomaterials , 2014, Particle and Fibre Toxicology.

[16]  Ivana Vinković Vrček,et al.  Does surface coating of metallic nanoparticles modulate their interference with in vitro assays , 2015 .

[17]  Yong Duan,et al.  A review of impedance measurements of whole cells. , 2016, Biosensors & bioelectronics.

[18]  W. Kreyling,et al.  Nanotoxicology , 2004, Occupational and Environmental Medicine.

[19]  Cotogno Giulio,et al.  Titanium Dioxide, NM-100, NM-101, NM-102, NM-103, NM-104, NM-105: Characterisation and Physico-Chemical Properties , 2014 .

[20]  Alexandra Kroll,et al.  Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays , 2011, Particle and Fibre Toxicology.

[21]  Chengxiao Zhang,et al.  Chip based single cell analysis for nanotoxicity assessment. , 2014, The Analyst.

[22]  Lawrence J. Fine,et al.  Occupational and environmental medicine. , 1996, Clinical privilege white paper.

[23]  Lang Tran,et al.  Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy , 2015, PloS one.

[24]  H. Norppa,et al.  Risk assessment of engineered nanomaterials and nanotechnologies--a review. , 2010, Toxicology.

[25]  Arkadiusz Pierzchalski,et al.  Microfluidic impedance‐based flow cytometry , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[26]  A. Krueger,et al.  In vitro cytotoxicity assessment of nanodiamond particles and their osteogenic potential. , 2018, Journal of biomedical materials research. Part A.

[27]  Dana Loomis,et al.  Work in Brief , 2006 .

[28]  S. Gawad,et al.  Micromachined impedance spectroscopy flow cytometer for cell analysis and particle sizing. , 2001, Lab on a chip.

[29]  Hicham Fenniri,et al.  Widespread Nanoparticle-Assay Interference: Implications for Nanotoxicity Testing , 2014, PloS one.

[30]  Alexandra Kroll,et al.  Interference of engineered nanoparticles with in vitro toxicity assays , 2012, Archives of Toxicology.

[31]  Marco Di Berardino,et al.  Rapid determination of general cell status, cell viability, and optimal harvest time in eukaryotic cell cultures by impedance flow cytometry , 2019, Applied Microbiology and Biotechnology.

[32]  H. Makse,et al.  A phase diagram for jammed matter , 2008, Nature.